NEUROMOLECULAR PHARMACEUTICALS has a total of 14 patent applications. Its first patent ever was published in 2004. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and Republic of Korea. Its main competitors in its focus markets pharmaceuticals and environmental technology are SUDA LTD, BAKULESH MAFATLAL KHAMAR and ISW GROUP INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 6 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | Republic of Korea | 3 | |
#4 | Canada | 1 | |
#5 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Fultz Timothy J | 10 |
#2 | Went Gregory T | 10 |
#3 | Burkoth Timothy S | 5 |
#4 | Porter Seth | 4 |
#5 | Meyerson Laurence R | 4 |
#6 | Meyerson Lawrence | 3 |
#7 | Chernoff David | 2 |
#8 | Lipton Stuart | 2 |
#9 | Laurence Meyerson | 1 |
#10 | Burkoth Terry | 1 |
Publication | Filing date | Title |
---|---|---|
ZA200704233B | Composition comprising a sustained release coating or matrix and an NMDA receptor antagonist, method for administration such NMDA antagonist to a subject | |
WO2007065036A2 | Therapeutic conjugates and methods of using same | |
WO2006089066A1 | Combinations therapy for treatment of demyelinating conditions | |
EP1799264A2 | Methods and compositions for treating migraine pain | |
EP1789028A2 | Compositions for treating nociceptive pain |